Abstract:Evolution by natural selection under complex and dynamic environmental conditions occurs through intricate and often counterintuitive trajectories affecting many genes and metabolic solutions. To study short- and long-term evolution of bacteria in vivo, we used the natural model system of cystic fibrosis (CF) infection. In this work, we investigated how and through which trajectories evolution of Pseudomonas aeruginosa occurs when migrating from the environment to the airways of CF patients, and specifically, we determined reduction of growth rate and metabolic specialization as signatures of adaptive evolution. We show that central metabolic pathways of three distinct Pseudomonas aeruginosa lineages coevolving within the same environment become restructured at the cost of versatility during long-term colonization. Cell physiology changes from naive to adapted phenotypes resulted in (i) alteration of growth potential that particularly converged to a slow-growth phenotype, (ii) alteration of nutritional requirements due to auxotrophy, (iii) tailored preference for carbon source assimilation from CF sputum, (iv) reduced arginine and pyruvate fermentation processes, and (v) increased oxygen requirements. Interestingly, although convergence was evidenced at the phenotypic level of metabolic specialization, comparative genomics disclosed diverse mutational patterns underlying the different evolutionary trajectories. Therefore, distinct combinations of genetic and regulatory changes converge to common metabolic adaptive trajectories leading to within-host metabolic specialization. This study gives new insight into bacterial metabolic evolution during long-term colonization of a new environmental niche.IMPORTANCE Only a few examples of real-time evolutionary investigations in environments outside the laboratory are described in the scientific literature. Remembering that biological evolution, as it has progressed in nature, has not taken place in test tubes, it is not surprising that conclusions from our investigations of bacterial evolution in the CF model system are different from what has been concluded from laboratory experiments. The analysis presented here of the metabolic and regulatory driving forces leading to successful adaptation to a new environment provides an important insight into the role of metabolism and its regulatory mechanisms for successful adaptation of microorganisms in dynamic and complex environments. Understanding the trajectories of adaptation, as well as the mechanisms behind slow growth and rewiring of regulatory and metabolic networks, is a key element to understand the adaptive robustness and evolvability of bacteria in the process of increasing their in vivo fitness when conquering new territories.

Continuous bioactivity-dependent evolution of an antibiotic biosynthetic pathway

Evolution-guided optimization of biosynthetic pathways

Dual phenazine gene clusters enable diversification during biosynthesis

Evolutionary dynamics of natural product biosynthesis in bacteria

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

CRAGE Enables Rapid Activation of Biosynthetic Gene Clusters in Undomesticated Bacteria.

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Stabilized gene duplication enables long-term selection-free heterologous pathway expression

Pathway Evolution Through a Bottlenecking-Debottlenecking Strategy and Machine Learning-Aided Flux Balancing

In vivo continuous evolution of metabolic pathways for chemical production

Evolving materials

Small changes in enzyme function can lead to surprisingly large fitness effects during adaptive evolution of antibiotic resistance

Antibiotic Skeletal Diversification via Differential Enoylreductase Recruitment and Module Iteration in trans -Acyltransferase Polyketide Synthases

Metabolic engineering and directed evolution for the production of pharmaceuticals

Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis

Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa

Discovery of microbial natural products by activation of silent biosynthetic gene clusters

Industrial Production of Antibiotics in Fungi: Current State, Deciphering the Molecular Basis of Classical Strain Improvement and Increasing the Production of High-Yielding Strains by the Addition of Low-Molecular Weight Inducers

Resurrecting ancestral antibiotics: unveiling the origins of modern lipid II targeting glycopeptides

Bacterial adaptation to sublethal antibiotic gradients can change the ecological properties of multitrophic microbial communities